FDA declines approval bid for Neffy, a needle-free EpiPen alternative
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Epipen
FDA rejects approval of epinephrine nasal spray
The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.
In-flight emergencies raise concerns about airlines' medical kit requirements
About one out of every 600 flights has an in-flight medical emergency, one report found.
Pfizer buying Mylan to create generic drug giant
Pfizer will split off its Upjohn unit, which makes Lipitor, to create a business with at least $19 billion in sales
Generic EpiPen alternative to hit the market soon
Sandoz Inc. plans to start selling its generic version early next year
"National crisis": EpiPen shortage keeping some kids out of school
U.S. is experiencing a shortage of the lifesaving device and parents are scrambling to find them
FDA extends EpiPen expiration dates because of shortage
To help in the short-term, the FDA and EpiPen manufacturer Pfizer are extending expiration dates for certain injectors that are expiring or close to expiring
EpiPen shortage has some relying on expired devices
Another generic version of the EpiPen won't come soon enough for users of life-saving medicine that's had manufacturing issues since May
FDA clears generic rival to high-priced EpiPen
Years after seeking federal approval, Israeli drugmaker gets nod to sell version of life-saving allergy treatment
Mylan CEO: Neulasta biosimilar will offer "significant savings" for patients
It's been nearly two years since the pharmaceutical giant took tremendous heat for the rising cost of EpiPens
FDA declares EpiPen shortage
As many as 400 patients have been unable to fill EpiPen prescriptions since May 2, according to reports
How Martin Shkreli changed the conversation on drug prices
Shkreli was sentenced to seven years in prison for cheating investors, but it was his role as outspoken CEO that may have made a bigger impact
"Don't let me die": Reported EpiPen failures spark more complaints
Mylan, company that created outrage with the dramatic price increase of the potentially life-saving drug, is on the defensive again
Alternatives emerge amid EpiPen price woes -- but at a questionable cost
We revisit the Henegar household, where two of their six children have severe allergies and rely on potentially lifesaving epinephrine auto-injectors
Lower-cost alternative to EpiPen OK’d by FDA
EpiPen’s maker sparked huge controversy when it hiked price of the emergency allergy med through the roof
Report reveals how many Americans have food allergies
Study shows which foods are most often linked to allergic reactions
Expired EpiPens may still save a life, study finds
But allergy experts warn it's better not to count on older EpiPens if you can replace them
Quick-thinking pharmacist saves customer
“I think something really bad is about to happen,” recalls Illinois man who developed a sudden, life-threatening condition
Mylan announces nationwide EpiPen recall
Some of the devices may have a defective part that does not allow for the activation of the injector in case of allergic reaction
Mylan recalls thousands of EpiPens over defect
Drugmaker says faulty part can stop some anti-allergy injectors from working properly, endangering users
What to do when your child has an allergy emergency
A report from a pediatricians' group offers a new "universal" action plan for doctors to give parents
Express Scripts' Tim Wentworth defends role in drug prices
The CEO of the largest pharmacy benefit manager defended its middleman role and discussed reasons behind rising drug prices
Mylan CEO on EpiPen drug price controversy: "I get the outrage"
The life-saving allergy drug became the lightning rod for scrutiny, as its price increased by nearly 500 percent over seven years
Mylan CEO says EpiPen controversy was "a window into a broken system"
Heather Bresch, head of the pharma giant, is opening up about the firestorm created by the nearly-500 percent increase in the price of life-saving allergy medicine
Cheaper generic EpiPen hits the market
Mylan's new version of the life-saving allergy drug is half the price
Oregon school shooter ID'd, used shotgun bought by mother, sources say
Trump waives tariffs on largest buyers of Russian oil
Exclusive
Sacramento mom says "hero" son shot, killed Oregon school shooter
Pope Leo to be discharged from hospital on Saturday, Vatican says
Katie Zacharia out as White House press secretary after first week
Vance says admin. must take action when ICE agents "screw up"
Live
Iran's president denies nuclear ambitions, says he's ready for talks
Sean "Diddy" Combs moved to prison in Pennsylvania
